-
1
-
-
0038025436
-
The role of T cells in psoriasis
-
Prinz J: The role of T cells in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 257-270.
-
(2003)
J Eur Acad Dermatol Venereol
, vol.17
, pp. 257-270
-
-
Prinz, J.1
-
2
-
-
0035724176
-
Psoriasis-epidemiology and clinical spectrum
-
review
-
Christophers E: Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-320, review.
-
(2001)
Clin Exp Dermatol
, vol.26
, pp. 314-320
-
-
Christophers, E.1
-
3
-
-
0345099477
-
A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience
-
Kane D, Stafford L, Bresnihan B, FitzGerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-1468.
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 1460-1468
-
-
Kane, D.1
Stafford, L.2
Bresnihan, B.3
Fitzgerald, O.4
-
4
-
-
33847279025
-
Pathogenesis and therapy of psoriasis
-
Lowes MA, Bowcock AM, Krueger JG: Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
-
(2007)
Nature
, vol.445
, pp. 866-873
-
-
Lowes, M.A.1
Bowcock, A.M.2
Krueger, J.G.3
-
6
-
-
33746951437
-
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
-
CASPAR Study Group
-
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2665-2673
-
-
Taylor, W.1
Gladman, D.2
Helliwell, P.3
Marchesoni, A.4
Mease, P.5
Mielants, H.6
-
7
-
-
69949125952
-
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment recommendations for psoriatic arthritis
-
Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, de Vlam K, Fiorentino D, Fitzgerald O, Gottlieb AB, McHugh NJ, Nash P, Qureshi AA, Soriano ER, Taylor WJ, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009; 68: 1387-1394.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1387-1394
-
-
Ritchlin, C.T.1
Kavanaugh, A.2
Gladman, D.D.3
Mease, P.J.4
Helliwell, P.5
Boehncke, W.H.6
De Vlam, K.7
Fiorentino, D.8
Fitzgerald, O.9
Gottlieb, A.B.10
McHugh, N.J.11
Nash, P.12
Qureshi, A.A.13
Soriano, E.R.14
Taylor, W.J.15
-
8
-
-
21144451096
-
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis
-
Fraser AD, van Kuijk AW, Westhovens R, Karim Z, Wakefield R, Gerards AH, Landewé R, Steinfeld SD, Emery P, Dijkmans BA, Veale DJ: A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005; 64: 859-864.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 859-864
-
-
Fraser, A.D.1
Van Kuijk, A.W.2
Westhovens, R.3
Karim, Z.4
Wakefield, R.5
Gerards, A.H.6
Landewé, R.7
Steinfeld, S.D.8
Emery, P.9
Dijkmans, B.A.10
Veale, D.J.11
-
9
-
-
4544388284
-
Biological therapies in the systemic management of psoriasis: International Consensus Conference
-
Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M, Ferrandiz C, Griffiths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K, Prinz J, Rzany B, Ronnevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhof P, Voorhees J, et al: Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol 2004; 151(suppl 69):3-17.
-
(2004)
Br J Dermatol
, vol.151
, Issue.SUPPL. 69
, pp. 3-17
-
-
Sterry, W.1
Barker, J.2
Boehncke, W.H.3
Bos, J.D.4
Chimenti, S.5
Christophers, E.6
De La Brassinne, M.7
Ferrandiz, C.8
Griffiths, C.9
Katsambas, A.10
Kragballe, K.11
Lynde, C.12
Menter, A.13
Ortonne, J.P.14
Papp, K.15
Prinz, J.16
Rzany, B.17
Ronnevig, J.18
Saurat, J.H.19
Stahle, M.20
Stengel, F.M.21
Van De Kerkhof, P.22
Voorhees, J.23
more..
-
10
-
-
84875211531
-
Efficacy and safety of subcutaneous anti-tumor necrosis factoralpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: An observational longterm study
-
Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS: Efficacy and safety of subcutaneous anti-tumor necrosis factoralpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational longterm study. Dermatology 2012; 225: 312-319.
-
(2012)
Dermatology
, vol.225
, pp. 312-319
-
-
Esposito, M.1
Giunta, A.2
Mazzotta, A.3
Zangrilli, A.4
Babino, G.5
Bavetta, M.6
Perricone, R.7
Chimenti, S.8
Chimenti, M.S.9
-
11
-
-
84877053271
-
Etanercept provides an effective, safe and flexible short-and long-term treatment regimen for moderate-to-severe psoriasis: A systematic review of current evidence
-
Strohal R, Chimenti S, Vena GA, Girolomoni G: Etanercept provides an effective, safe and flexible short-and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence. J Dermatolog Treat 2012; 24: 199-208.
-
(2012)
J Dermatolog Treat
, vol.24
, pp. 199-208
-
-
Strohal, R.1
Chimenti, S.2
Vena, G.A.3
Girolomoni, G.4
-
12
-
-
80055095434
-
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis update from the Italian Society for Rheumatology
-
Italian Society for Rheumatology
-
Salvarani C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L, Scarpa R, Spadaro A, Matucci-Cerinic M, Olivieri I, Italian Society for Rheumatology: Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis update from the Italian Society for Rheumatology. Clin Exp Rheumatol 2011; 29(suppl 66):S28-S41.
-
(2011)
Clin Exp Rheumatol
, vol.29
, Issue.SUPPL. 66
-
-
Salvarani, C.1
Pipitone, N.2
Marchesoni, A.3
Cantini, F.4
Cauli, A.5
Lubrano, E.6
Punzi, L.7
Scarpa, R.8
Spadaro, A.9
Matucci-Cerinic, M.10
Olivieri, I.11
-
13
-
-
0002683625
-
Generation of fully human anti-TNF antibody D2E7
-
Salfeld J, Kaymakcalan Z, Tracey D, Roberts A, Kamen R: Generation of fully human anti-TNF antibody D2E7. Arthritis Rheum 1998; 41(suppl):S57.
-
(1998)
Arthritis Rheum
, vol.41
, Issue.SUPPL.
-
-
Salfeld, J.1
Kaymakcalan, Z.2
Tracey, D.3
Roberts, A.4
Kamen, R.5
-
14
-
-
84864401979
-
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: Longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GOREVEAL)
-
Kavanaugh A, Mease P: Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GOREVEAL). J Rheumatol Suppl 2012; 89: 90-93.
-
(2012)
J Rheumatol Suppl
, vol.89
, pp. 90-93
-
-
Kavanaugh, A.1
Mease, P.2
-
15
-
-
84871085190
-
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab
-
Wagner CL, Visvanathan S, Elashoff M, Mc-Innes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M, Beutler A, Gladman D, Kavanaugh A: Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Ann Rheum Dis 2013; 72: 83-88.
-
(2013)
Ann Rheum Dis
, vol.72
, pp. 83-88
-
-
Wagner, C.L.1
Visvanathan, S.2
Elashoff, M.3
Mc-Innes, I.B.4
Mease, P.J.5
Krueger, G.G.6
Murphy, F.T.7
Papp, K.8
Gomez-Reino, J.J.9
Mack, M.10
Beutler, A.11
Gladman, D.12
Kavanaugh, A.13
-
16
-
-
84857238069
-
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: Current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
-
Ash Z, Gaujoux-Viala C, Gossec L, Hensor EM, FitzGerald O, Winthrop K, van der Heijde D, Emery P, Smolen JS, Marzo-Ortega H: A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 2012; 71: 319-326.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 319-326
-
-
Ash, Z.1
Gaujoux-Viala, C.2
Gossec, L.3
Hensor, E.M.4
Fitzgerald, O.5
Winthrop, K.6
Van Der Heijde, D.7
Emery, P.8
Smolen, J.S.9
Marzo-Ortega, H.10
-
17
-
-
82955236087
-
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
-
European League Against Rheumatism
-
Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, FitzGerald O, Aletaha D, Balint P, Boumpas D, Braun J, Breedveld FC, Burmester G, Cañete JD, de Wit M, Dagfinrud H, de Vlam K, et al, European League Against Rheumatism: European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012; 71: 4-12.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 4-12
-
-
Gossec, L.1
Smolen, J.S.2
Gaujoux-Viala, C.3
Ash, Z.4
Marzo-Ortega, H.5
Van Der Heijde, D.6
Fitzgerald, O.7
Aletaha, D.8
Balint, P.9
Boumpas, D.10
Braun, J.11
Breedveld, F.C.12
Burmester, G.13
Cañete, J.D.14
De Wit, M.15
Dagfinrud, H.16
De Vlam, K.17
-
18
-
-
33745080328
-
Development of classification and response criteria for rheumatic diseases
-
Classification and Response Criteria Subcommittee of the Committee on Quality Measures, American College of Rheumatology
-
Singh J A, Solomon D H, Dougados M, Felson D, Hawker G, Katz P, Paulus H, Wallace C, Classification and Response Criteria Subcommittee of the Committee on Quality Measures, American College of Rheumatology: Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006; 55: 348-352.
-
(2006)
Arthritis Rheum
, vol.55
, pp. 348-352
-
-
Singh, J.A.1
Solomon, D.H.2
Dougados, M.3
Felson, D.4
Hawker, G.5
Katz, P.6
Paulus, H.7
Wallace, C.8
-
19
-
-
84864438913
-
Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial
-
Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, Gómez-Reino J, Papp K, Baratelle A, Xu W, Mudivarthy S, Mack M, Rahman MU, Xu Z, Zrubek J, Beutler A: Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum 2012; 64: 2504-2517.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 2504-2517
-
-
Kavanaugh, A.1
Van Der Heijde, D.2
McInnes, I.B.3
Mease, P.4
Krueger, G.G.5
Gladman, D.D.6
Gómez-Reino, J.7
Papp, K.8
Baratelle, A.9
Xu, W.10
Mudivarthy, S.11
Mack, M.12
Rahman, M.U.13
Xu, Z.14
Zrubek, J.15
Beutler, A.16
-
20
-
-
77955370347
-
Continuous treatment of plaque-type psoriasis with etanercept: An observational longterm experience
-
Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S: Continuous treatment of plaque-type psoriasis with etanercept: an observational longterm experience. Int J Immunopathol Pharmacol 2010; 23: 503-509.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 503-509
-
-
Esposito, M.1
Giunta, A.2
Mazzotta, A.3
Babino, G.4
Talamonti, M.5
Chimenti, M.S.6
Chimenti, S.7
-
21
-
-
80051670470
-
Anti-TNF? Discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission?
-
Chimenti MS, Graceffa D, Perricone R: Anti-TNF? discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission? Autoimmun Rev 2011; 10: 636-640
-
(2011)
Autoimmun Rev
, vol.10
, pp. 636-640
-
-
Chimenti, M.S.1
Graceffa, D.2
Perricone, R.3
-
22
-
-
84883577100
-
The first decade of biologic TNF antagonists in clinical practice: Lessons learned, unresolved issues and future directions
-
Sfikakis PP: The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 2010; 11: 180-210.
-
(2010)
Curr Dir Autoimmun
, vol.11
, pp. 180-210
-
-
Sfikakis, P.P.1
-
23
-
-
65449189497
-
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: Observational study from the British Society of Rheumatology Biologics Register
-
British Society for Rheumatology Biologics Register
-
Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DP, British Society for Rheumatology Biologics Register: Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Res Ther 2009; 11:R52.
-
(2009)
Arthritis Res Ther
, vol.11
-
-
Saad, A.A.1
Ashcroft, D.M.2
Watson, K.D.3
Hyrich, K.L.4
Noyce, P.R.5
Symmons, D.P.6
-
24
-
-
79951691645
-
Changes in disease characteristics and response rates among patients in the United Kingdom starting antitumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008
-
British Society for Rheumatology Biologics Register (BSRBR)
-
Hyrich KL, Watson KD, Lunt M, Symmons DP, British Society for Rheumatology Biologics Register (BSRBR): Changes in disease characteristics and response rates among patients in the United Kingdom starting antitumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. Rheumatology (Oxford) 2011; 50: 117-123.
-
(2011)
Rheumatology (Oxford)
, vol.50
, pp. 117-123
-
-
Hyrich, K.L.1
Watson, K.D.2
Lunt, M.3
Symmons, D.P.4
|